Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.

Source:http://linkedlifedata.com/resource/pubmed/id/21233194

Download in:

View as

General Info

PMID
21233194